We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+21.69%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$150M
AUM Growth
+$13M
Cap. Flow
-$2.13M
Cap. Flow %
-1.42%
Top 10 Hldgs %
33.6%
Holding
92
New
24
Increased
18
Reduced
19
Closed
31

Top Buys

Rank Stock Value
1
MLM icon
Martin Marietta Materials
MLM
+$3.6M
2
ICLR icon
Icon
ICLR
+$3.13M
3
EW icon
Edwards Lifesciences
EW
+$3.1M
4
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$3.06M
5
TWTR
Twitter, Inc.
TWTR
+$2.75M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$3.76M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
+$2.87M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$2.47M
4
AGN
Allergan Inc
AGN
+$2.4M
5
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
+$2.18M

Sector Composition

Rank Sector Weight
1 Healthcare 40.29%
2 Industrials 15.71%
3 Communication Services 12.16%
4 Consumer Discretionary 11.17%
5 Materials 2.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACAD icon
51
Acadia Pharmaceuticals
ACAD
$4.87B
$1.14M 0.76%
35,000
-83,500
-70% -$2.87M
JUNO
52
DELISTED
Juno Therapeutics, Inc.
JUNO
$1.09M 0.73%
18,000
+5,000
+38% +$243K
PRKS icon
53
CALL
United Parks & Resorts
PRKS
$2.16B
$1.03M 0.69%
+53,500
New +$985K
XENT
54
DELISTED
Intersect ENT, Inc
XENT
$982K 0.66%
+38,000
New +$869K
PARA
55
CALL
DELISTED
Paramount Global Class B
PARA
$806K 0.54%
+13,300
New +$777K
ACAD icon
56
CALL
Acadia Pharmaceuticals
ACAD
$4.87B
$691K 0.46%
21,200
+18,000
+563% +$619K
HQY icon
57
HealthEquity
HQY
$8.7B
$640K 0.43%
25,600
-2,000
-7% -$43.4K
ALNY icon
58
Alnylam Pharmaceuticals
ALNY
$30B
$574K 0.38%
+5,500
New +$557K
AGIO icon
59
Agios Pharmaceuticals
AGIO
$1.9B
$471K 0.31%
5,000
-22,000
-81% -$2.47M
ISEE
60
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$419K 0.28%
+9,000
New +$467K
ANAC
61
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$347K 0.23%
6,000
-41,500
-87% -$1.76M
ABBV icon
62
AbbVie
ABBV
$438B
– –
-57,399
Closed -$3.76M
AVDL
63
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-93,000
Closed -$1.59M
BHC icon
64
CALL
Bausch Health
BHC
$2.36B
– –
-6,000
Closed -$858K
BMRN icon
65
BioMarin Pharmaceuticals
BMRN
$11.7B
– –
-8,000
Closed -$723K
BMY icon
66
CALL
Bristol-Myers Squibb
BMY
$130B
– –
-20,000
Closed -$1.18M
COO icon
67
Cooper Companies
COO
$14.6B
– –
-12,000
Closed -$486K
EHTH icon
68
CALL
eHealth
EHTH
$42.5M
– –
-17,900
Closed -$446K
EHTH icon
69
eHealth
EHTH
$42.5M
– –
-65,500
Closed -$1.63M
IBN icon
70
ICICI Bank
IBN
$109B
– –
-132,000
Closed -$1.39M
JVA icon
71
Coffee Holding Co
JVA
$19.5M
– –
-18,400
Closed -$94K
LULU icon
72
lululemon athletica
LULU
$14B
– –
-37,500
Closed -$2.09M
MPAA icon
73
Motorcar Parts of America
MPAA
$259M
– –
-66,000
Closed -$2.05M
OMER icon
74
Omeros
OMER
$945M
– –
-31,000
Closed -$768K
PBYI icon
75
Puma Biotechnology
PBYI
$408M
– –
-2,500
Closed -$473K
1 2
3
4

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
SC
Soundwatch Capital Rowayton, Connecticut $793M AUM 15.45% 1-Year Est. Return

Atika Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Atika Capital Management held 92 positions worth $150M, up 9.5% from $137M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Atika Capital Management's Q1 2015 filing shows 24 new, 18 increased, 19 reduced and 31 closed positions. Its largest new stake was Martin Marietta Materials: 28,000 shares worth $3.92M. The largest sale was AbbVie, an estimated $3.76M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 41% a quarter earlier, followed by Industrials and Communication Services.

  • Atika Capital Management's largest Q1 2015 buy was Martin Marietta Materials: 28,000 shares worth $3.92M.
  • Atika Capital Management added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q1 2015, an estimated $1.63M increase.
  • Atika Capital Management's biggest Q1 2015 reduction was Acadia Pharmaceuticals, cutting an estimated $2.87M.
  • Atika Capital Management fully exited AbbVie in Q1 2015, selling an estimated $3.76M.
  • Atika Capital Management's ten largest holdings make up 34% of its $150M portfolio in Q1 2015.
  • Atika Capital Management opened 24 new positions and closed 31 in Q1 2015.
  • Atika Capital Management's portfolio value rose 9.5% quarter-over-quarter to $150M.

Based on Atika Capital Management's 13F filing for Q1 2015, filed 15 May 2015.